{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 3, "transaction_limit": 160, "filters": {"q": "", "ticker": "NTLA", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 3, "acquisition_count": 0, "disposal_count": 3, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 219750.73, "disposal_value_label": "$219.8K", "net_value": -219750.73, "net_value_label": "$-219.8K", "flow_tone": "negative", "largest_value_label": "$91.2K", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 3, "value": "219750.7300", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$219.8K"}], "days": [{"transaction_date": "2026-07-01", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 100.0}, {"transaction_date": "2026-07-02", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 100.0}, {"transaction_date": "2026-07-22", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 100.0}], "side_mix": {"acquisitions": 0, "disposals": 3, "acquisition_share": 0.0, "disposal_share": 100.0}}, "company_flows": [{"symbol": "NTLA", "name": "Intellia Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 219750.73, "disposed_value_label": "$219.8K", "net_value": -219750.73, "net_value_label": "$-219.8K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/ntla/", "research_links": {"chart": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/", "report": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/report/", "factor": "/factors/ticker/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/"}}], "company_overview": [{"symbol": "NTLA", "name": "Intellia Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "filings": 3, "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 219750.73, "disposed_value_label": "$219.8K", "net_value": -219750.73, "net_value_label": "$-219.8K", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/ntla/", "research_links": {"chart": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/", "report": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/report/", "factor": "/factors/ticker/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/"}}], "transactions": [{"symbol": "NTLA", "name": "Intellia Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "DULAC, EDWARD J III", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8111.0, "share_price": 11.25, "transaction_value": 91248.75, "fetched_at": "2026-07-31T10:50:47.038502+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ntla/", "research_links": {"chart": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/", "report": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/report/", "factor": "/factors/ticker/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/"}}, {"symbol": "NTLA", "name": "Intellia Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "DULAC, EDWARD J III", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 4677.0, "share_price": 18.0, "transaction_value": 84186.0, "fetched_at": "2026-07-22T11:03:27.469432+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ntla/", "research_links": {"chart": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/", "report": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/report/", "factor": "/factors/ticker/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/"}}, {"symbol": "NTLA", "name": "Intellia Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "DUBE, MICHAEL P", "executive_title": "VP, Chief Accounting Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2641.0, "share_price": 16.78, "transaction_value": 44315.98, "fetched_at": "2026-07-22T11:03:27.471811+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ntla/", "research_links": {"chart": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/", "report": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/report/", "factor": "/factors/ticker/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}